How many days should one take Enasidenib as a course of treatment?

Enasidenib is a drug used to treat certain types of acute myeloid leukemia. According to clinical practice, the treatment course of ensidipine is usually 28 days. However, the specific length of treatment may vary depending on the patient's specific situation and the recommendations of the doctor. In subjects with relapsed and refractory acute myeloid leukemia (AML), ensidipine pharmacokinetics support convenient once-daily 100 mg dosing, with food intake having no significant effect on absorption and reaching a steady state by day 29 of treatment. If ensidipine is being held due to toxicity, clinicians should be aware that etaxitinib will continue to be present in the body for a long time after the last dose.